Home/IGC Pharma/Prof. Pablo Arbeláez

PP

Prof. Pablo Arbeláez

Advisor (AI)

Therapeutic Areas

Alzheimer's Disease Central Nervous System Disorders

IGC Pharma Pipeline

Drug	Indication	Phase
IGC-AD1	Agitation in Alzheimer's Dementia	Phase 2
TGR-63	Early-Moderate Stage Alzheimer's (Aβ Plaques)	Preclinical
IGC-1C	Alzheimer's (Tau pathology)	Preclinical
IGC-M3	Alzheimer's (Aβ Plaques aggregation)	Preclinical
IGC-LMP	Alzheimer's Agitation Symptoms (Neuroinflammation)	Preclinical

Leadership Team at IGC Pharma

Claudia Grimaldi

VP, CCO, PFO, & Director

Chairman of the Board

Prof. Chuanhai Cao, Ph.D.

Advisor (Pharmaceutical Sciences)

Prof. Elliot L. Hong

Advisor (Psychiatry)

Prof. Joseph Fortunak, Ph.D.

Advisor (Chemistry & Pharmaceutical Sciences)

Prof. T. Govindaraju, Ph.D, FRSC

Advisor (Bioorganic Chemistry)

View full IGC Pharma profile